Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial
Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial
Indian Express
0 shares
1 views
You might like
Related news coverage
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine
Mid-Day
The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission..